Clinical Trial Update: Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intraperitoneal infusion of autologous monocytes with Sylatron (peginterferon alfa-2b) and Actimmune (interferon gamma-1b) in women wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• ACTIMMUNE (interferon gamma-1b)
• Sylatron (peginterferon alfa-2b)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: TERMINATED | Results posted: 2021-06-16